Brief: Neodynamics Received FDA Clearance For Pulse Biopsy System Neonavia
08/09/2022 19:36
Sept 8 (Reuters) - Neodynamics AB (publ) NEOD.ST :
* NEODYNAMICS RECEIVED FDA CLEARANCE FOR PULSE BIOPSY SYSTEM
NEONAVIA®
Source text for Eikon: ID:nWkr5jkP0X
Further company coverage: NEOD.ST
((Reuters.briefs@thomsonreuters.com;))
Recent news on Neodynamics AB (publ)
See all newsBrief: Neodynamics' Stock Is Delisted From Nasdaq First North
Brief: Salénterprise Ownership In NeoDynamics Rises To About 46% After Offer
Brief: NeoDynamics Intends To Apply For Delisting
Brief: Neodynamics Chooses Not To Advise Shareholders On Decision To Accept Offer From Salénterprise
Brief: Salénterprise Makes Cash Offer To Shareholders Neodynamics